Royal Bank of Canada’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
Other funds holding INSM
DGM
VPM
VCM
BBA
Royal Bank of Canada's INSM Position: Q1 2026 in Review
Royal Bank of Canada increased its Insmed (INSM) stake by 3.2% in Q1 2026, buying an estimated $2.5M and bringing the position to 523,101 shares worth $85.5M. The position accounts for 0.02% of the portfolio, ranked #692.
Royal Bank of Canada first reported a position in INSM in Q2 2013 and has held it in 50 quarters since. The position peaked at $195M in Q3 2025. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Royal Bank of Canada held 523,101 shares of Insmed worth $85.5M as of Q1 2026.
- Royal Bank of Canada bought 16,290 Insmed shares in Q1 2026, an estimated $2.5M.
- Insmed made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #692 holding.
- Royal Bank of Canada first reported a position in Insmed in Q2 2013 and has held it in 50 quarters since.
- Royal Bank of Canada's Insmed position peaked at $195M in Q3 2025.
- 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.